Skip to main content
SpringerLink
Log in

Recursive partitioning analysis classification and graded prognostic assessment for non-small cell lung cancer patients with brain metastasis: A retrospective cohort study

  • Original Article
  • Published:
Chinese Journal of Cancer Research

Abstract

Objective|

To assess prognostic factors and validate the effectiveness of recursive partitioning analysis (RPA) classes and graded prognostic assessment (GPA) in 290 non-small cell lung cancer (NSCLC) patients with brain metastasis (BM).

Methods

From Jan 2008 to Dec 2009, the clinical data of 290 NSCLC cases with BM treated with multiple modalities including brain irradiation, systemic chemotherapy and tyrosine kinase inhibitors (TKIs) in two institutes were analyzed. Survival was estimated by Kaplan-Meier method. The differences of survival rates in subgroups were assayed using log-rank test. Multivariate Cox’s regression method was used to analyze the impact of prognostic factors on survival. Two prognostic indexes models (RPA and GPA) were validated respectively.

Results

All patients were followed up for 1-44 months, the median survival time after brain irradiation and its corresponding 95% confidence interval (95% CI) was 14 (12.3–15.8) months. 1-, 2- and 3-year survival rates in the whole group were 56.0%, 28.3%, and 12.0%, respectively. The survival curves of subgroups, stratified by both RPA and GPA, were significantly different (P<0.001). In the multivariate analysis as RPA and GPA entered Cox’s regression model, Karnofsky performance status (KPS) ≥ 70, adenocarcinoma subtype, longer administration of TKIs remained their prognostic significance, RPA classes and GPA also appeared in the prognostic model.

Conclusion

KPS ≥70, adenocarcinoma subtype, longer treatment of molecular targeted drug, and RPA classes and GPA are the independent prognostic factors affecting the survival rates of NSCLC patients with BM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Posner JB. Management of brain metastases. Rev Neurol 1992; 148: 477–487.

    PubMed  CAS  Google Scholar 

  2. Walker AE, Robins M, Weinfeld FD. Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 1985; 35: 219–226.

    PubMed  CAS  Google Scholar 

  3. Davey P. Brain metastases: treatment options to improve outcomes. CNS Drugs 2002; 16:325–338.

    Article  PubMed  CAS  Google Scholar 

  4. Shahidi H, Kvale PA. Long-term survival following surgical treatment of solitary brain metastasis in non-small cell lung cancer. Chest 1996; 109: 271–276.

    Article  PubMed  CAS  Google Scholar 

  5. Gaspar LE, Mehta MP, Patchell RA, et al. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010; 96:17–32.

    Article  PubMed  Google Scholar 

  6. Stafinski T, Jhangri GS, Yan E, et al. Effectiveness of stereotactic radiosurgery alone or in combination with whole brain radiotherapy compared to conventional surgery and/or whole brain radiotherapy for the treatment of one or more brain metastases: a systematic review and meta-analysis. Cancer Treat Rev 2006; 32:203–213.

    Article  PubMed  Google Scholar 

  7. Linskey ME, Andrews DW, Asher AL, et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010; 96:45–68.

    Article  PubMed  Google Scholar 

  8. Kalkanis SN, Kondziolka D, Gaspar LE, et al. The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010; 96:33–43.

    Article  PubMed  Google Scholar 

  9. Souquet PJ, Chauvin F, Boissel JP, et al. Polychemotherapy in advanced non small cell lung cancer: a meta-analysis. Lancet 1993; 342:19–21.

    Article  PubMed  CAS  Google Scholar 

  10. Kim DY, Lee KW, Yun T, et al. Efficacy of platinum based chemotherapy after cranial radiation in patients with brain metastases from non-small cell lung cancer. Oncol Rep 2005; 14:207–211.

    PubMed  Google Scholar 

  11. Kim KH, Lee J, Lee JL, et al. Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases? Lung Cancer 2010; 68:258–263.

    Article  PubMed  Google Scholar 

  12. Mehta MP, Paleologos NA, Mikkelsen T, et al. The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010; 96:71–83.

    Article  PubMed  Google Scholar 

  13. Ceresoli GL, Cappuzzo F, Gregorc V, et al. Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial. Ann Oncol 2004; 15:1042–1047.

    Article  PubMed  CAS  Google Scholar 

  14. Rosell R, Taron M, Sanchez JJ, et al. Setting the benchmark or tailoring treatment with EGFR tyrosine kinase inhibitors. Future Oncol 2007; 3:277–283.

    Article  PubMed  CAS  Google Scholar 

  15. Fekrazad MH, Ravindranathan M, Jones DV Jr. Response of intracranial metastases to erlotinib therapy. J Clin Oncol 2007; 25:5024–5026.

    Article  PubMed  Google Scholar 

  16. von Pawel J, Wagner H, Duell T, et al. Erlotinib in patients with previously irradiated, recurrent brain metastases from non-small cell lung cancer: two case reports. Onkologie 2008; 31:123–126.

    Article  Google Scholar 

  17. Gounant V, Wislez M, Poulot V, et al. Subsequent brain metastasis responses to epidermal growth factor receptor tyrosine kinase inhibitors in a patient with non-small-cell lung cancer. Lung Cancer 2007; 58:425–428.

    Article  PubMed  Google Scholar 

  18. Nishi N, Kawai S, Yonezawa T, et al. Effect of gefitinib on brain metastases from non-small cell lung cancer. Neurol Med Chir 2006; 46:504–507.

    Article  Google Scholar 

  19. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997; 37: 745–751.

    Article  PubMed  CAS  Google Scholar 

  20. Gaspar LE, Scott C, Murray K, et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 2000; 47:1001–1006.

    Article  PubMed  CAS  Google Scholar 

  21. Sperduto PW, Berkey B, Gaspar LE, et al. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008; 70:510–514.

    Article  PubMed  Google Scholar 

  22. Golden DW, Lamborn KR, McDermott MW, et al. Prognostic factors and grading systems for overall survival in patients with radiosurgery for brain metastases: variation by primary site. J Neurosurg 2008; 109(Suppl):77–86.

    PubMed  Google Scholar 

  23. Kepka L, Cieslak E, Bujko K, et al. Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis. Acta Oncol 2005; 44:389–398.

    Article  PubMed  Google Scholar 

  24. Schuette W. Treatment of brain metastases from lung cancer: chemotherapy. Lung Cancer 2004; 45(Suppl 2):S253–S257.

    Article  PubMed  Google Scholar 

  25. Porta R, Sanchez-Torres JM, Paz-Ares L, et al. Brian metastases from lung cancer responding to erlotinib: the importance of EGFR mutation. Eur Respir J 2011; 37:624–631.

    Article  PubMed  CAS  Google Scholar 

  26. Pan HC, Sheehan J, Stroila M, et al. Gamma knife surgery for brain metastases from lung cancer. J Neurosurg 2005; 102(Suppl):128–133.

    Article  PubMed  Google Scholar 

  27. Agboola O, Benoit B, Cross P, et al. Prognostic factors derived from recursive partition analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases. Int J Radiat Oncol Biol Phys 1998; 42:155–159.

    PubMed  CAS  Google Scholar 

  28. Sanghavi SN, Miranpuri SS, Chappell R, et al. Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 2001; 51:426–434.

    Article  PubMed  CAS  Google Scholar 

  29. Cannady SB, Cavanaugh KA, Lee SY, et al. Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: a retrospective study. Int J Radiat Oncol Biol Phys 2004; 58:253–258.

    Article  PubMed  Google Scholar 

  30. Sperduto PW, Chao ST, Sneed PK, et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010; 77:655–661.

    Article  PubMed  Google Scholar 

  31. Nakagawa H, Miyawaki Y, Fujita T, et al. Surgical treatment of brain metastases of lung cancer: retrospective analysis of 89 cases. J Neurol Neurosurg Psychiatry 1994; 57:950–956.

    Article  PubMed  CAS  Google Scholar 

  32. Saitoh Y, Fujisawa T, Shiba M, et al. Prognostic factors in surgical treatment of solitary brain metastasis after resection of non-small-cell lung cancer. Lung Cancer 1999; 24:99–106.

    Article  PubMed  CAS  Google Scholar 

  33. Galicich JH, Sundaresan N, Arbit E, et al. Surgical treatment of single brain metastasis: factors associated with survival. Cancer 1980; 45: 381–386.

    Article  PubMed  CAS  Google Scholar 

  34. White KT, Fleming TR, Laws ER Jr. Single metastasis to the brain. Surgical treatment in 122 consecutive patients. Mayo Clin Proc 1981; 56: 424–428.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zhejiang Traditional Chinese Medicine University, Hangzhou, 310053, China

    Cai-xing Sun & Xu-li Meng

  2. Department of Neurooncology, Zhejiang Cancer Hospital, Hangzhou, 310022, China

    Cai-xing Sun, Tao Li & Hong-jian Yang

  3. Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, 310022, China

    Xiao Zheng

  4. Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, 310022, China

    Ju-fen Cai

  5. Zhejiang People’s Hospital, Hangzhou, 310024, China

    Zheng Wang

Authors
  1. Cai-xing Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tao Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiao Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ju-fen Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xu-li Meng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hong-jian Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Zheng Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tao Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sun, Cx., Li, T., Zheng, X. et al. Recursive partitioning analysis classification and graded prognostic assessment for non-small cell lung cancer patients with brain metastasis: A retrospective cohort study. Chin. J. Cancer Res. 23, 177–182 (2011). https://doi.org/10.1007/s11670-011-0177-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11670-011-0177-1

Key words

Search

Navigation